Viemed Healthcare, Inc. (VMD)

Viemed Healthcare Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	10.68	13.5	17.54	12.84	16.91	28.41
Cash & Short-Term Investments	10.68	13.5	17.54	12.84	16.91	28.41
Cash Growth	-46.64%	-23.03%	36.61%	-24.09%	-40.46%	-8.30%
Accounts Receivable	32.23	25.59	24.91	18.45	15.38	12.82
Other Receivables	-	0.23	-	-	0.03	1.89
Receivables	32.23	25.81	24.91	18.45	15.41	14.72
Inventory	5.27	5.05	4.32	4.63	3.57	2.46
Prepaid Expenses	5.79	4.13	6.11	2.45	3.85	1.73
Total Current Assets	53.97	48.49	52.88	38.37	39.74	47.31
Property, Plant & Equipment	81.69	82.36	79.16	76.85	68.44	62.85
Long-Term Investments	3.18	2.79	2.79	3.9	4.16	2.16
Goodwill	58.94	58.94	32.99	29.77	-	-
Other Intangible Assets	1.16	1.29	0.85	0.57	-	-
Long-Term Deferred Tax Assets	5.29	5.29	8.4	4.56	3.12	4.79
Other Long-Term Assets	-	-	-	0.89	1.59	0.86
Total Assets	204.22	199.15	177.07	154.9	117.04	117.96

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	10.99	7.33	5.32	4.18	2.65	3.24
Accrued Expenses	23.19	22.16	20.16	17.58	11.09	8.88
Current Portion of Long-Term Debt	0.72	1.09	0.41	1.07	-	1.48
Current Portion of Leases	1.42	1.2	0.86	0.93	0.5	0.46
Current Income Taxes Payable	1.83	-	3.88	2.15	-	-
Current Unearned Revenue	8	7.52	6.69	6.21	4.62	3.75
Other Current Liabilities	1.75	1.75	-	-	-	-
Total Current Liabilities	47.89	41.06	37.33	32.12	18.86	17.81
Long-Term Debt	6.37	11.29	3.59	6	-	4.51
Long-Term Leases	3.09	2.36	2.01	2.32	0.2	0.27
Other Long-Term Liabilities	0.9	0.92	0.85	0.56	0.89	0.56
Total Liabilities	58.26	55.63	43.77	41	19.95	23.14

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	17.98	16.91	23.37	18.7	15.12	14.01
Additional Paid-In Capital	17.81	21.74	18.34	15.7	12.13	7.75
Retained Earnings	108.24	102.89	89.69	79.5	69.85	73.34
Comprehensive Income & Other	-	-	-	-	-	-0.28
Total Common Equity	144.03	141.55	131.39	113.9	97.09	94.82
Minority Interest	1.94	1.98	1.91	-	-	-
Shareholders' Equity	145.96	143.52	133.3	113.9	97.09	94.82
Total Liabilities & Equity	204.22	199.15	177.07	154.9	117.04	117.96

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	11.6	15.95	6.87	10.32	0.69	6.72
Net Cash (Debt)	-0.92	-2.45	10.67	2.52	16.22	21.69
Net Cash Growth	-	-	324.41%	-84.49%	-25.22%	11.73%
Net Cash Per Share	-0.02	-0.06	0.26	0.06	0.41	0.53
Filing Date Shares Outstanding	38.09	38.6	39.52	38.76	38.17	39.68
Total Common Shares Outstanding	38.09	38.02	39.13	38.51	38.05	39.64
Working Capital	6.07	7.44	15.55	6.24	20.88	29.5
Book Value Per Share	3.78	3.72	3.36	2.96	2.55	2.39
Tangible Book Value	83.93	81.32	97.56	83.56	97.09	94.82
Tangible Book Value Per Share	2.20	2.14	2.49	2.17	2.55	2.39
Land	2.57	2.57	2.57	2.57	2.57	2.57
Buildings	8.59	8.49	8.31	7.95	7.04	7.68
Machinery	130.08	127.92	122.75	115.65	97.74	33.36
Leasehold Improvements	0.68	0.72	0.66	0.35	0.3	0.3

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error